Cellectar Biosciences, Inc. (CLRB)
Nasdaq: CLRB · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2004
Who owns Cellectar Biosciences, Inc.
As filed with the SECHolders of 5% or more
9
Balyasny Asset Management L.P. holds 9.99% of Common Stock, as its SCHEDULE 13G filed Aug 14, 2026 says.
Directors and officers
9
report now, of 20 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 9 named at left.
Holders of 5% or moreshare of the class, as filed
Balyasny Asset Management L.P.
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock
SilverArc Capital Management, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Class A Common Stock
Bleichroeder LP
SCHEDULE 13G · filed Aug 13, 2026 · Common Shares · 4.61% in Feb 13, 2026
Empery Asset Management, LP
SCHEDULE 13G · filed Aug 4, 2026 · Common Stock, $0.00001 par value per share
Janus Henderson Group PLC
SCHEDULE 13G · filed Jun 5, 2026 · Common Stock
StemPoint Capital LP
SCHEDULE 13G · filed Aug 14, 2026 · Common stock, par value $0.00001
Stonepine Capital Management, LLC
SCHEDULE 13G · filed May 11, 2026 · Common Stock
Caligan Partners LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.00001 par value per share
Rosalind Advisors, Inc.
SCHEDULE 13G/A · filed Feb 10, 2026 · Common Shares · 9.9% in Feb 3, 2025
Mitchell P. Kopin
SCHEDULE 13G · filed Jul 8, 2025 · Common stock, par value $0.00001 per share · reported falling below 5%
Hexstone Capital LLC
SCHEDULE 13G/A · filed Feb 4, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 5.6% in Aug 8, 2025
Orin Hirschman
SCHEDULE 13G/A · filed Jan 27, 2025 · Common Stock, $0.00001 par value · reported falling below 5%
Lytton Laurence W
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock · reported falling below 5%, from 8.8% in Feb 13, 2025
ADAR1 Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.00001 par value per share · reported falling below 5%
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common stock, par value $0.00001 · reported falling below 5%, from 5.73% in Feb 14, 2025
What CLRB reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 13, 2025.
Insider tradesForm 4
1sales
2purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 23 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Caruso James V | President & CEO | 0 | $0 | 0 | 1 | $0 |
| Longcor Jarrod | Chief Operating Officer | 0 | $0 | 0 | 1 | $0 |
| Neis John | director | 1 | $0 | 0 | 0 | $0 |